SEC Tracker
Get the app

Dyne Therapeutics DYN

John Cox (Officer) plans to sell 4,067 DYN shares, about $48,356

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Mar 5, 2025
  2. Broker: Stifel Nicolaus & Company Inc.
  3. Shares acquired by: Restricted Stock Unit

All of John Cox's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 4,061 shares at $11.83 on Mar 5, 2025 ยท Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Dyne Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Akebia Therapeutics AKBA public float $946M, Jun 30, 2025
  2. Viridian Therapeutics VRDN public float $943M, Jun 30, 2025
  3. Collegium Pharmaceutical COLL public float $926M, Jun 30, 2025
  4. Neogen NEOG public float $972M, Nov 30, 2025
  5. Ardelyx ARDX public float $924M, Jun 30, 2025